Clincosm LogoSign in Get a demo

Plasma Cell Leukemia

Showing 26 - 31 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plasma Cell Leukemia Trial in United States (Bortezomib, Daratumumab, Dexamethasone)

Withdrawn
  • Plasma Cell Leukemia
  • Duarte, California
  • +4 more
Dec 17, 2018

Multiple Myeloma, Plasma Cell Leukemia Trial in Tampa (Bortezomib, Melphalan, PBSCT)

Completed
Has Results
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 20, 2017

Multiple Myeloma, Plasma Cell Leukemia Trial in Philadelphia (Bendamustine)

Withdrawn
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 19, 2016

Multiple Myeloma, Plasma Cell Leukemia Trial in Ann Arbor (Fludarabine/Busulfan x 4 days, stem cell transplant)

Terminated
Has Results
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Fludarabine/Busulfan x 4 days
  • stem cell transplant
  • Ann Arbor, Michigan
    University of Michigan,Department of Internal Med. Hematology- O
Mar 3, 2016

Multiple Myeloma, Multiple Myeloma in Relapse, Mantle Cell Lymphoma in Relapse Trial in South Africa, United States (SNS01-T)

Unknown status
  • Multiple Myeloma
  • +5 more
  • SNS01-T
  • Little Rock, Arkansas
  • +6 more
Sep 9, 2014

Plasma Cell Leukemia, Multiple Myeloma Trial in Beijing (Bortezomib, Liposome doxorubicin, Dexamethasone)

Unknown status
  • Plasma Cell Leukemia
  • Multiple Myeloma
  • Beijing, Beijing, China
    Beijing Clinical Service Center
Sep 21, 2011